AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33443925 — intervention group
Group type: COMPARATOR
Intervention: Oral ε‐aminocaproic acid (EACA) 2000 mg per dose, three doses: 2 hours before surgery, and 6 and 12 hours after surgery.
Number of subjects: 102
Study 36380681 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS
Number of subjects: 204
Study 36380681 — intervention group
Group type: COMPARATOR
Intervention: Sham TEAS
Number of subjects: 204
Study 33447903 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-view radiographic examination
Number of subjects: 58
Study 33447903 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-view radiographic examination (including PA scaphoid view)
Number of subjects: 58
Study 33447903 — intervention group
Group type: COMPARATOR
Intervention: Individual views (various)
Number of subjects: 58
Study 32519795 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide (≥5 mg for non-T2DM and ≥4.5 mg for T2DM)
Number of subjects: 0
Study 32519795 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide (5/5/10/10 or 5/5/10/15 mg) in T2DM participants
Number of subjects: 0
Study 32519795 — intervention group
Group type: COMPARATOR
Intervention: Semaglutide
Number of subjects: 0
Study 32519795 — intervention group
Group type: COMPARATOR
Intervention: GIP analogue alone
Number of subjects: 0
Study 32519795 — intervention group
Group type: COMPARATOR
Intervention: Dulaglutide
Number of subjects: 0
Study 34255711 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help smartphone app MCT & More for 4 weeks
Number of subjects: 400
Study 34255711 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 400
Study 36418362 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid model HXGBRS
Number of subjects: 554
Study 36418362 — intervention group
Group type: COMPARATOR
Intervention: Hybrid model HBPNNRS
Number of subjects: 554
Study 36418362 — intervention group
Group type: COMPARATOR
Intervention: Hybrid model HBNRS
Number of subjects: 554
Study 36418362 — intervention group
Group type: COMPARATOR
Intervention: Hybrid model HBRS
Number of subjects: 554
Study 36418362 — intervention group
Group type: COMPARATOR
Intervention: Hybrid model HRFRS
Number of subjects: 554
Study 34993458 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of DAPT score to treating physicians
Number of subjects: 585
Study 34993458 — intervention group
Group type: COMPARATOR
Intervention: Control group (no provision of DAPT score)
Number of subjects: 585
Study 34993458 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of DAPT score to treating physicians (DAPT score ≥ 2)
Number of subjects: 585
Study 34993458 — intervention group
Group type: COMPARATOR
Intervention: Control group (DAPT score < 2)
Number of subjects: 585
Study 35219222 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) program, 8 sessions over 4 weeks
Number of subjects: 84
Study 35219222 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 84
Study 32252004 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF-I with oral estrogen-progesterone (EP)
Number of subjects: 0
Study 32252004 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF-I alone
Number of subjects: 0
Study 32252004 — intervention group
Group type: EXPERIMENTAL
Intervention: EP alone
Number of subjects: 0
Study 32252004 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF-I and EP
Number of subjects: 0
Study 32252004 — intervention group
Group type: COMPARATOR
Intervention: Neither
Number of subjects: 0
Study 33879005 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-resistant depression (TRD)
Number of subjects: 10449
Study 35634818 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention (PRODET®), 12-week program, 2 days/week for 50 minutes
Number of subjects: 67
Study 35588245 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/day viloxazine extended-release
Number of subjects: 439
Study 32274541 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care (SOC) + radiotherapy to the prostate (RT)
Number of subjects: 0
Study 32274541 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical prostatectomy (RP)
Number of subjects: 0
Study 32274541 — intervention group
Group type: EXPERIMENTAL
Intervention: Metastasis-directed therapy (MDT)
Number of subjects: 0
Study 34581608 — intervention group
Group type: EXPERIMENTAL
Intervention: AI algorithm
Number of subjects: 1531
Study 34581608 — intervention group
Group type: COMPARATOR
Intervention: No AI algorithm (Control)
Number of subjects: 1531
Study 33231117 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral approaches to aphasia treatment
Number of subjects: 0
Study 33231117 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive brain stimulation techniques
Number of subjects: 0
Study 33231117 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy options
Number of subjects: 0
Study 33231117 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled behavioral treatments
Number of subjects: 0
Study 33037974 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 13
Study 33037974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 36180765 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytotoxic edema (CE) detected within 7-12 days after symptom onset
Number of subjects: 20
Study 36180765 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytotoxic edema (CE) within 7-12 days
Number of subjects: 20
Study 33440966 — intervention group
Group type: EXPERIMENTAL
Intervention: Special position cushion (experimental group)
Number of subjects: 450
Study 33440966 — intervention group
Group type: COMPARATOR
Intervention: Conventional hip sponge pads (control group)
Number of subjects: 450
Study 35277436 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory Learning and Action (PLA)
Number of subjects: 1000
Study 35277436 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth
Number of subjects: 1000
Study 33576113 — intervention group
Group type: COMPARATOR
Intervention: LTI-291 (3, 10, 30, and 90 mg single doses)
Number of subjects: 80
Study 33576113 — intervention group
Group type: COMPARATOR
Intervention: LTI-291 (3, 10, 30, and 60 mg multiple doses)
Number of subjects: 80
Study 33576113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32889869 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodeno-jejunal bypass liner (DJBL)
Number of subjects: 82
Study 36074934 — intervention group
Group type: EXPERIMENTAL
Intervention: LED photobiomodulation therapy (PBMT) with red (630 nm) and infrared (850 nm) wavelengths
Number of subjects: 0
Study 36074934 — intervention group
Group type: COMPARATOR
Intervention: Control (right side of abdomen, no treatment)
Number of subjects: 0
Study 33914197 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (INS) intervention
Number of subjects: 8
Study 33914197 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrates (CARBS) intervention
Number of subjects: 8
Study 33914197 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 8
Study 34897211 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral metronidazole
Number of subjects: 120
Study 34897211 — intervention group
Group type: COMPARATOR
Intervention: Control (oral placebo)
Number of subjects: 120
Study 34897211 — intervention group
Group type: COMPARATOR
Intervention: Control (topical placebo)
Number of subjects: 120
Study 33080379 — intervention group
Group type: EXPERIMENTAL
Intervention: Decídetexto mobile smoking cessation intervention
Number of subjects: 618
Study 33080379 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (printed smoking cessation materials and referral to telephone quitline)
Number of subjects: 618
Study 33714500 — intervention group
Group type: EXPERIMENTAL
Intervention: Suboccipital fascial release (SFR) technique
Number of subjects: 40
Study 33714500 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated group, UG)
Number of subjects: 40
Study 33036567 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised home-based standardized physical activity program for 3 months
Number of subjects: 432
Study 33036567 — intervention group
Group type: COMPARATOR
Intervention: Recommended adapted physical activity (via a booklet)
Number of subjects: 432
Study 33036567 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised home-based standardized physical activity program
Number of subjects: 432
Study 33086883 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score based on candidate predictors (age at admission, socioeconomic status, family history of asthma/atopy, previous asthma hospitalizations)
Number of subjects: 1171
Study 33086883 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (comparison group in general ward)
Number of subjects: 1171
Study 33642048 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle-brachial index (ABI) measurement
Number of subjects: 92
Study 33642048 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to ABI measurement
Number of subjects: 92
Study 32757427 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit with feedback on a quarterly basis over a 12-month implementation period.
Number of subjects: 0
Study 32757427 — intervention group
Group type: COMPARATOR
Intervention: Quarterly audits only (without feedback).
Number of subjects: 0
Study 32757427 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined data from both groups.
Number of subjects: 0
Study 36121706 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 757
Study 36121706 — intervention group
Group type: COMPARATOR
Intervention: Intravascular imaging guidance
Number of subjects: 757
Study 33933030 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality Circle Deprescribing Module (QC-DeMo) intervention
Number of subjects: 58
Study 33933030 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 58
Study 33534231 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological mesh closure
Number of subjects: 104
Study 33534231 — intervention group
Group type: COMPARATOR
Intervention: Primary perineal closure
Number of subjects: 104
Study 33130139 — intervention group
Group type: EXPERIMENTAL
Intervention: Single burr hole
Number of subjects: 192
Study 33130139 — intervention group
Group type: COMPARATOR
Intervention: Double burr hole
Number of subjects: 192
Study 35815264 — intervention group
Group type: EXPERIMENTAL
Intervention: Er Xian Decoction combined with Baduanjin Exercise (EXD + BE)
Number of subjects: 50
Study 35815264 — intervention group
Group type: COMPARATOR
Intervention: Er Xian Decoction (EXD)
Number of subjects: 50
Study 35815264 — intervention group
Group type: COMPARATOR
Intervention: Baduanjin Exercise (BE)
Number of subjects: 50
Study 33334164 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behaviour therapy for insomnia (CBT-I)
Number of subjects: 21
Study 35482129 — intervention group
Group type: EXPERIMENTAL
Intervention: 1565-nm non-ablative fractional laser combined with low-dose compound betamethasone topical application
Number of subjects: 38
Study 35482129 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 38
Study 32352812 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist assessment of NSSI history
Number of subjects: 1364
Study 32352812 — intervention group
Group type: COMPARATOR
Intervention: Single-item assessment of NSSI history
Number of subjects: 1364
Study 34856530 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 FiO2 (80% oxygen)
Number of subjects: 258
Study 34856530 — intervention group
Group type: COMPARATOR
Intervention: 0.3 FiO2 (30% oxygen)
Number of subjects: 258
Study 33686698 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronically elevated GDF15 levels
Number of subjects: 0
Study 32537715 — intervention group
Group type: EXPERIMENTAL
Intervention: Fedratinib 500 mg once-daily for 15 days
Number of subjects: 0
Study 32537715 — intervention group
Group type: COMPARATOR
Intervention: Control (no fedratinib)
Number of subjects: 0
Study 35997691 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 0
Study 33684828 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro Kind home visitation program
Number of subjects: 109
Study 32635661 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic preparation containing Lactobacillus and Bifidobacterium strains and fructooligosaccharides
Number of subjects: 80
Study 32635661 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic preparation
Number of subjects: 80
Study 32635661 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic treatment
Number of subjects: 80
Study 32635661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 36067791 — intervention group
Group type: EXPERIMENTAL
Intervention: Honglilai Vaginal Cream
Number of subjects: 435
Study 36067791 — intervention group
Group type: COMPARATOR
Intervention: Premarin Vaginal Cream
Number of subjects: 435
Study 32401633 — intervention group
Group type: EXPERIMENTAL
Intervention: CPX-351 (135 units/m2 on days 1, 3, and 5)
Number of subjects: 38
Study 32401633 — intervention group
Group type: EXPERIMENTAL
Intervention: FLAG (fludarabine 30 mg/m2/dose on days 1-5; cytarabine 2000 mg/m2/dose on days 1-5; granulocyte-colony stimulating factor 5 mg/kg/dose, days 1-5 and day 15)
Number of subjects: 38
Study 33509414 — intervention group
Group type: EXPERIMENTAL
Intervention: STAND intervention (N = 84)
Number of subjects: 179
Study 33509414 — intervention group
Group type: COMPARATOR
Intervention: TSP intervention (N = 95)
Number of subjects: 179
Study 33191253 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia cases
Number of subjects: 291780
Study 35364620 — intervention group
Group type: EXPERIMENTAL
Intervention: Values-based cognitive behavioural therapy (V-CBT) delivered within 6 months post-injury, 10 sessions starting 1 week post-randomization (group A)
Number of subjects: 91
Study 35364620 — intervention group
Group type: COMPARATOR
Intervention: Values-based cognitive behavioural therapy (V-CBT) delivered within 6 months post-injury, 10 sessions starting 3 months post-randomization (group B)
Number of subjects: 91
Study 33690227 — intervention group
Group type: EXPERIMENTAL
Intervention: Training data group (drugs with known pharmacokinetic and physical parameters)
Number of subjects: 70
Study 33690227 — intervention group
Group type: COMPARATOR
Intervention: Test data group (validation of the prediction equation)
Number of subjects: 70
Study 32952016 — intervention group
Group type: EXPERIMENTAL
Intervention: CoEDTA
Number of subjects: 2
Study 32952016 — intervention group
Group type: EXPERIMENTAL
Intervention: CrEDTA
Number of subjects: 2
Study 32952016 — intervention group
Group type: COMPARATOR
Intervention: RedSol (reducing solution)
Number of subjects: 2
Study 35471721 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2963016 insulin glargine (LY IGlar)
Number of subjects: 210
Study 35471721 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (IGlar)
Number of subjects: 210
Study 35871064 — intervention group
Group type: EXPERIMENTAL
Intervention: KEβHB drink
Number of subjects: 18
Study 35871064 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 18
Study 32505857 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mL retained cystoscopy fluid
Number of subjects: 120
Study 32505857 — intervention group
Group type: COMPARATOR
Intervention: Complete bladder emptying
Number of subjects: 120
Study 32059694 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed Health Choices podcast
Number of subjects: 523
Study 32059694 — intervention group
Group type: COMPARATOR
Intervention: Control (typical public service announcements about health issues)
Number of subjects: 523
Study 35436968 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg swing exercise
Number of subjects: 114
Study 35436968 — intervention group
Group type: COMPARATOR
Intervention: Quadriceps strengthening exercise
Number of subjects: 114
Study 33866315 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (0.12 g)
Number of subjects: 0
Study 33866315 — intervention group
Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 0
Study 35503610 — intervention group
Group type: EXPERIMENTAL
Intervention: Medihoney dressing material applied to the donor site in the test group
Number of subjects: 20
Study 35503610 — intervention group
Group type: COMPARATOR
Intervention: No dressing material applied in the control group
Number of subjects: 20
Study 32360392 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS with cognitive training (CT)
Number of subjects: 44
Study 32360392 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS with cognitive training (CT)
Number of subjects: 44
Study 33772416 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading intervention
Number of subjects: 216
Study 33772416 — intervention group
Group type: COMPARATOR
Intervention: ADHD treatment
Number of subjects: 216
Study 33772416 — intervention group
Group type: COMPARATOR
Intervention: Combined treatments
Number of subjects: 216
Study 33772416 — intervention group
Group type: COMPARATOR
Intervention: ADHD intervention
Number of subjects: 216
Study 36128948 — intervention group
Group type: EXPERIMENTAL
Intervention: 21 mm circular stapler (CSD)
Number of subjects: 20
Study 36128948 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 mm linear stapler (LSD)
Number of subjects: 20
Study 32196804 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent balance‐specific exercise programme with additional workshops on active and healthy ageing, N = 50
Number of subjects: 150
Study 32196804 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent wellness programme, N = 50
Number of subjects: 150
Study 32196804 — intervention group
Group type: COMPARATOR
Intervention: Regular Special Olympics athletic training, N = 50
Number of subjects: 150
Study 34444940 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Addiction (FA)
Number of subjects: 448
Study 34444940 — intervention group
Group type: COMPARATOR
Intervention: No Food Addiction (non-FA)
Number of subjects: 448
Study 34066238 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Frequency Questionnaire (FFQ)
Number of subjects: 150
Study 32865690 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior calyceal access (group 1)
Number of subjects: 126
Study 32865690 — intervention group
Group type: COMPARATOR
Intervention: Inferior calyceal access (group 2)
Number of subjects: 126
Study 32663977 — intervention group
Group type: EXPERIMENTAL
Intervention: ESC/MEM
Number of subjects: 41
Study 32663977 — intervention group
Group type: COMPARATOR
Intervention: ESC/PBO
Number of subjects: 41
Study 35850141 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified low dose protocol with tin filtering
Number of subjects: 65
Study 35850141 — intervention group
Group type: COMPARATOR
Intervention: Conventional low dose protocol without tin filtering
Number of subjects: 65
Study 34023839 — intervention group
Group type: EXPERIMENTAL
Intervention: Xerostomia Inventory (XI)
Number of subjects: 354
Study 34023839 — intervention group
Group type: EXPERIMENTAL
Intervention: Xerostomia Inventory (XI) as a gold standard
Number of subjects: 354
Study 34023839 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistical regression model adjusted for tooth mobility, bone or respiratory diseases, and consumption of anxiolytics and antidepressants
Number of subjects: 354
Study 35689905 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing counseling plus nicotine replacement therapy (NRT)
Number of subjects: 324
Study 35689905 — intervention group
Group type: COMPARATOR
Intervention: Brief advice to quit (standard care) plus NRT
Number of subjects: 324
Study 32723318 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual case management plus motivational interviewing (MI)
Number of subjects: 450
Study 32723318 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual case management plus stratified vocational advice intervention (SVAI)
Number of subjects: 450
Study 32723318 — intervention group
Group type: COMPARATOR
Intervention: Usual case management alone
Number of subjects: 450
Study 36166567 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) + Action Observation (AO)
Number of subjects: 0
Study 36166567 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-based MI training system with EMG feedback
Number of subjects: 0
Study 33067258 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB) treatment with small-size balloon predilation (pBVR<0.8)
Number of subjects: 30
Study 33067258 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB) treatment with large-size balloon predilation (pBVR 0.8-1.0)
Number of subjects: 30
Study 33067258 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up for long-term outcomes
Number of subjects: 30
Study 32204222 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 80mg plus pravastatin 20mg twice daily until 35 weeks gestation
Number of subjects: 0
Study 32204222 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 80mg
Number of subjects: 0
Study 35365190 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) applied once at the level of the lesion, five segments above/below, and on the plantar surface of both feet within the first 48 h after trauma (energy flux density: 0.1–0.19 mJ/mm2, frequency: 2–5 Hz)
Number of subjects: 82
Study 35365190 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 82
Study 33542265 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tRNS
Number of subjects: 19
Study 33542265 — intervention group
Group type: COMPARATOR
Intervention: Sham tRNS
Number of subjects: 19
Study 32460879 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron oral solution (six doses over 48 hours)
Number of subjects: 1030
Study 32460879 — intervention group
Group type: COMPARATOR
Intervention: Placebo (six doses over 48 hours)
Number of subjects: 1030
Study 35695006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 35695006 — intervention group
Group type: COMPARATOR
Intervention: 40 mg Revacept
Number of subjects: 160
Study 35695006 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg Revacept
Number of subjects: 160
Study 33788003 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO grading scale
Number of subjects: 200
Study 33788003 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO vs RTOG
Number of subjects: 200
Study 33788003 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO vs CTCAE
Number of subjects: 200